Gilead Sciences (Foster City, CA) r...
Gilead Sciences (Foster City, CA) reported 96-week comes from a study of Hepsera (adefovir dipivoxil 10 mg) in enslaves with hepatitis B "e" antigen-negative chronic hepatitis B virus (HBV) The contemplation was a randomized, double-blind, placebo-controlled clinical trial of 184 controls Subjects were randomized to receive the medicine once daily or placebo for 48 weeks. Following the first 48 weeks of treatment, exposes who had ...
|